Does UMBRALISIB Cause Decreased appetite? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Decreased appetite have been filed in association with UMBRALISIB. This represents 3.8% of all adverse event reports for UMBRALISIB.
11
Reports of Decreased appetite with UMBRALISIB
3.8%
of all UMBRALISIB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Decreased appetite From UMBRALISIB?
Of the 11 reports, 1 (9.1%) resulted in death, 2 (18.2%) required hospitalization, and 1 (9.1%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UMBRALISIB. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does UMBRALISIB Cause?
Diarrhoea (47)
Nausea (36)
Disease progression (30)
Fatigue (30)
Covid-19 (16)
Nervous system disorder (15)
Death (14)
Asthenia (13)
Off label use (13)
Product dose omission issue (12)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which UMBRALISIB Alternatives Have Lower Decreased appetite Risk?
UMBRALISIB vs UMECLIDINIUM
UMBRALISIB vs UMECLIDINIUM\VILANTEROL TRIFENATATE
UMBRALISIB vs UMIFENOVIR
UMBRALISIB vs UNSPECIFIED INGREDIENT
UMBRALISIB vs UPADACITINIB